Vancomycin: Clinical Trials

95 trials of Vancomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

45 completed, 18 terminated, 13 unknown, 9 recruiting. 95 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 495Completed 45, Terminated 18, Unknown 13, Recruiting 9, Not yet recruiting 5, Withdrawn 3, Enrolling by invitation 2

Follow Vancomycin: new trials by email Literature Review of Vancomycin trials Research Report on Vancomycin

Trials (filtered) newest first · largest first

All 95 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
Vancomycin (POC), Fidaxomicin - Inflammatory Bowel Disease (IBD), Clostridioides Difficile Infection
Phase 4Not yet recruitingBrigham and Women's Hospital602026-09-012025-11-03
Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia
Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer
Phase 4Not yet recruitingHospital Universitari Vall d'Hebron Research Institute1362026-06-012026-05-15
Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies
Topical Vancomycin Powder, Standard Perioperative Care - Hydrocephalus, Ventriculoperitoneal Shunt Infection
Phase 4Not yet recruitingAssiut University1642026-05-012026-04-23
Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial
Cefazolin, Vancomycin - Infection, Surgical Site
Phase 4Not yet recruitingHamilton Health Sciences Corporation380002026-03-012026-03-12
A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
Vancomycin, Piperacillin-tazobactam, Cefepime - Acute Kidney Injury
Phase 4RecruitingUniversity of Pennsylvania7502026-01-282026-02-13
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
Tissue Expander (TE), Vancomycin and Gentamicin, Stimulan Rapid Cure - Breast Cancer
Phase 4RecruitingMemorial Sloan Kettering Cancer Center3922025-10-212026-07-10
Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?
Early Dual IV Antibiotic Therapy - MRSA, Early Dual IV Antibiotic Therapy - MSSA, Single Agent IV Antibiotic Therapy - MRSA - Staphylococcus Aureus Bacteremia
Phase 4Enrolling by invitationWest Virginia University3002025-09-152026-09-17
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Daptomycin for Injection, Vancomycin (IV) - Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia
Phase 4RecruitingTodd C. Lee MD MPH FIDSA3002024-11-142026-09-09
Linezolid or Vancomycin Surgical Site Infection Prophylaxis
Vancomycin Injection, Linezolid Injection - Antibiotic Prophylaxis, General Surgery
Phase 4RecruitingAssistance Publique Hopitaux De Marseille11602024-11-122026-02-05
Powdered Intrawound Vancomycin in Open Fractures Trial
Vancomycin 1000 MG - Open Fracture, Trauma
Phase 4Not yet recruitingUniversity of Manitoba3502024-11-012024-09-19
Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy
cephalosporin, Second tier antibiotic (Vancomycin) - Surgical Site Infection, Beta-lactam Allergy
Phase 4WithdrawnUniversity of Texas Southwestern Medical Center2024-08-162023-12-15
Vancomycin in TKAs
Vancomycin - Total Knee Arthroplasty
Phase 4RecruitingUniversity of California, San Diego302024-06-102026-06-03
Antibiotics and Vaccine Immune Responses Study
BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule - Vaccine Response Impaired
Phase 4RecruitingSouth Australian Health and Medical Research Institute3482023-11-232026-09-17
Comparing Oral Versus Parenteral Antimicrobial Therapy
Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection
Phase 4TerminatedWest Virginia University942023-08-042025-08-26
Continuous vs. Intermittent Infusion Vancomycin
Vancomycin Continuous Infusion, Vancomycin Intermittent Infusion - Vancomycin
Phase 4CompletedAaron Cook372023-05-222025-12-15
Efficacy of Diluted Betadine vs Antibiotic Installation Before Surgical Wound Closure in Prevention of Post Cardiac Surgery Wound Infection
Betadine, Vancomycin - Surgical Wound Infection
Phase 4UnknownAssiut University802022-09-012022-03-11
The Effect of Intrawound Vancomycin Powder in Spine Surgery
Vancomycin - Spine Disease
Phase 4RecruitingWindsor-Essex Compassionate Care Community16432022-03-272024-04-23
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin, Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline - Endocarditis
Phase 4TerminatedWest Virginia University52022-03-162026-05-05
Staphylococcus Aureus Network Adaptive Platform Trial
Cefazolin, Penicillin, Clindamycin - Staphylococcus Aureus Bacteremia
Phase 4RecruitingUniversity of Melbourne80002022-02-162026-05-06
Bezlotoxumab Versus FMT for Multiple Recurrent CDI
Bezlotoxumab, Fecal Microbiota Transplantation (FMT), Vancomycin oral - Clostridium Infections, Clostridioides Difficile
Phase 4WithdrawnLeiden University Medical Center2022-01-012023-03-28

Showing 20 of 95. Sign in to see all of them.

Conditions studied

Infections (12)  ·  Clostridium Infections (11)  ·  Surgical Wound Infection (11)  ·  Staphylococcal Infections (5)  ·  Endocarditis (4)  ·  Febrile Neutropenia (4)  ·  Fractures, Open (4)  ·  Bacteremia (3)  ·  Cellulitis (3)  ·  Diarrhea (3)  ·  Neoplasms (3)  ·  Pneumonia (3)  ·  Pneumonia, Ventilator-Associated (3)  ·  Acute Kidney Injury (2)  ·  Arrhythmias, Cardiac (2)

Sponsors

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (4)  ·  Pfizer (3)  ·  Population Health Research Institute (3)  ·  West Virginia University (3)  ·  Assiut University (2)  ·  Astellas Pharma Europe Ltd. (2)  ·  Forest Laboratories (2)  ·  University Hospital, Ghent (2)  ·  University of California, San Diego (2)  ·  University of Cincinnati (2)  ·  University of Colorado, Denver (2)  ·  Washington University School of Medicine (2)  ·  Aaron Cook (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Baylor College of Medicine (1)

Countries

United States (55)  ·  Canada (9)  ·  Spain (7)  ·  Belgium (6)  ·  France (5)  ·  Australia (4)  ·  Germany (4)  ·  Poland (4)  ·  Puerto Rico (4)  ·  Russia (4)  ·  United Kingdom (4)  ·  Argentina (3)  ·  Austria (3)  ·  Brazil (3)  ·  Greece (3)

Top investigators

Donald Poretz, MD (2)  ·  Pieter De Cock, Prof (2)  ·  A. Krishna Rao, MD, MS (1)  ·  Aaron M Cook, PharmD (1)  ·  Aki Havulinna, MD, PhD (1)  ·  Alan G Smulian, M.B.B.Ch. (1)  ·  Andrew Krahn, MD (1)  ·  Andrew Maternowski, MD (1)  ·  Anne Smits, MD (1)  ·  Arif R Sawari, MD, MSc, MBA (1)  ·  Arif R. Sarwari, MD, MSc, MBA (1)  ·  Brandon Oto (1)

Results publications

PMID 24011955, PMID 15327406, PMID 15509186, PMID 18719064, PMID 19222623, PMID 19376733, PMID 20350927, PMID 20458318, PMID 21412147, PMID 22083832, PMID 22770644, PMID 24279701, PMID 25048851, PMID 26196695, PMID 26529126, PMID 26547411, PMID 26592763, PMID 27600290, PMID 28101605, PMID 29273269, PMID 29608680, PMID 29937192, PMID 30355158, PMID 30858203, PMID 30911926, PMID 30915685, PMID 30995208, PMID 31833540, PMID 32011685, PMID 32029130, PMID 32222460, PMID 32859235, PMID 33413809, PMID 33441409, PMID 33560404, PMID 34017999, PMID 34303860, PMID 35833959, PMID 37797310, PMID 37837651, PMID 39934879, PMID 40260835, PMID 41159585, PMID 41419216, PMID 41433510, PMID 41974145, PMID 42102324, PMID 42308484, PMID 42309115

NIH funding

2025 (1), R21AI176298 (1)